Latest Regulatory News

Westpac’s 1Q25 update reveals a resilient $1.7 billion net profit and strong loan growth despite margin pressures and economic headwinds.

Freightways Group Limited has announced an ordinary dividend of NZD 0.22352941 per share for the six months ending December 31, 2024, payable on April 1, 2025. The dividend is fully unfranked and reflects the company’s ongoing cash flow strength.

The A2 Milk Company has announced its first-ever interim dividend of NZD 0.085 per share, signaling confidence in its financial position and commitment to shareholders.

Contact Energy Limited has announced a fully unfranked dividend of NZD 0.1847 per share, combining ordinary and supplementary components, payable in March 2025.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

Contact Energy reported a 12% rise in EBITDAF to $404 million for 1H25, driven by new geothermal assets and strategic contracts, while net profit fell 7% due to market volatility and acquisition costs.

Carly Holdings Limited has agreed to merge its car subscription operations with Carbar Holdings in a $3.8 million deal, aiming to create a larger, more competitive player in Australia’s growing car subscription sector.

Many Peaks Minerals Limited has amended its previous ASX announcement on auger sampling at the Ferké Gold Project to enhance regulatory compliance, while continuing to advance exploration with diamond drilling and planned air core and RC programs.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.

Macarthur Minerals Limited reported a comprehensive loss of AUD 252,771 for Q4 2024, marking a sharp reversal from the prior year's profit. The company is navigating reduced exploration spending and strategic asset sales while facing ongoing funding challenges.